Published in Healthcare Finance, Tax and Law Weekly, February 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Advanced Magnetics.
Report 1: Advanced Magnetics (AMAG) announced positive results from a phase III clinical trial of ferumoxytol as an intravenous (IV) iron replacement therapeutic that was presented at the American Society of Nephrology's Renal Week 2006 Annual Meeting in San Diego, California.
A poster entitled "Ferumoxytol as Intravenous Iron Replacement Therapy in Chronic Kidney Disease (CKD) Patients Not on Dialysis - Evaluation of Safety and Efficacy in Two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly